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AbstrACt
Objective To assess the association between continuity 
of provider-adjusted regularity of general practitioner (GP) 
contact and unplanned diabetes-related hospitalisation or 
emergency department (ED) presentation.
Design Cross-sectional study.
setting Individual-level linked self-report and 
administrative health service data from New South Wales, 
Australia.
Participants 27 409 survey respondents aged ≥45 years 
with a prior history of diabetes and at least three GP 
contacts between 1 July 2009 and 30 June 2015.
Main outcome measures Unplanned diabetes-related 
hospitalisations or ED presentations, associated costs and 
bed days.
results Twenty-one per cent of respondents had 
an unplanned diabetes-related hospitalisation or ED 
presentation. Increasing regularity of GP contact was 
associated with a lower probability of hospitalisation or 
ED presentation (19.9% for highest quintile, 23.5% for the 
lowest quintile). Conditional on having an event, there was 
a small decrease in the number of hospitalisations or ED 
presentations for the low (−6%) and moderate regularity 
quintiles (−8%), a reduction in bed days (ranging from 
−30 to −44%) and a reduction in average cost of between 
−23% and −41%, all relative to the lowest quintile. 
When probability of diabetes-related hospitalisation or ED 
presentation was included, only the inverse association 
with cost remained significant (mean of $A3798 to 
$A6350 less per individual, compared with the lowest 
regularity quintile). Importantly, continuity of provider did 
not significantly modify the effect of GP regularity for any 
outcome.
Conclusions Higher regularity of GP contact—that is 
more evenly dispersed, not necessarily more frequent 
care—has the potential to reduce secondary healthcare 
costs and, conditional on having an event, the time spent 
in hospital, irrespective of continuity of provider. These 
findings argue for the advocacy of regular care, as distinct 
from solely continuity of provider, when designing policy 
and financial incentives for GP-led primary care.
IntrODuCtIOn
In line with other developed countries, 
chronic diseases predominate in Australia 
accounting for 66% of disease burden in 
2011 and 73% of deaths in 2013.1 2 One 
strategy to address this challenge is to shift 
care from hospital to primary care. This 
is because primary care treatments are 
strengths and limitations of this study
 ► This study is the first to assess the impact of regu-
larity of general practitioner (GP) contact adjusting 
for continuity of (GP) provider.
 ► This study used two-part and zero inflated negative 
binomial models which allowed associations to be 
expressed conditional on having an event and incor-
porating the probability of having an event.
 ► The assessment of the impact of provider-adjusted 
regularity of GP contact across subpopulations pro-
vides information that will facilitate more targeted 
approaches to primary care policy development.
 ► This study included a comprehensive range of 
self-reported data on health and socioeconomic sta-
tus not often available in linked data studies in ad-
dition to administrative data on current and previous 
health service utilisation.
 ► This was a cross-sectional observational study over 
a 6-year period which limits the ability to infer cau-
sality. However, the inclusion of both health service 
use and outcomes prior to the study period in the 
modelling allowed us to partially ameliorate this 
limitation.
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generally less costly3 and hospitals are not well-suited to 
manage chronic conditions.4 This approach is consistent 
with a body of literature on Ambulatory Care Sensitive 
Conditions; conditions for which hospitalisation may be 
avoidable if effective outpatient treatment is provided.5 In 
recognition of this developing evidence base, a National 
Chronic Disease Strategy was devised in Australia in 2005, 
which promoted the integration and continuity of care.6 
Similar initiatives have been introduced in the United 
Kingdom7 and the USA.8 
Although chronic disease management in primary 
care has the potential to be less costly and more appro-
priate for patients, primary care services in Australia have 
historically been episodic and reactive. Such models of 
care are likely inadequate for patients with chronic condi-
tions and multimorbidities. Evidence to date suggests 
integrated care models with a focus on chronic disease 
management are important for increased health system 
efficiency and are more responsive to consumers’ needs 
and preferences.9 10 In countries such as Australia, where 
primary care operates on a fee-for-service basis, incentive 
payments can be used as a mechanism to modify primary 
care provider behaviours in terms of how healthcare is 
accessed and delivered.11 Improving planned chronic 
disease management by general practitioners (GPs), 
rather than focusing on provider continuity may be appro-
priate in health systems with diverse funding arrange-
ments, as there is evidence from the United Kingdom12 13 
and the USA14 that continuity of provider is falling.
Better linkage of care, with the GP as the central care 
provider, is underpinned by the theoretical notion that 
better continuity of care improves health and health 
system outcomes. GP provided care is publicly subsidised 
in Australia through the universal healthcare access 
programme, Medicare. GPs also provide a gateway to 
specialist and some allied health services, as a referral 
is required for publicly subsidised specialist or allied 
healthcare. The definition of ‘continuity’ is inconsistent 
and the mechanisms by which different components of 
continuity with a GP reduces hospitalisation are not well 
described. Most continuity indices focus on continuity of 
provider.15 16 One measure of continuity of provider is 
the usual provider concentration index (UPC) which is 
a simple measure of the proportion of visits to the same 
provider.17 Under most previous measures, a patient 
seeing a single provider on a regular, frequent basis may 
have a similar continuity score to a patient seeing a single 
provider on a very fragmented basis. For this reason, a 
body of work from Australia has evolved to explore the 
concept of ‘regularity’ of GP contact.18–20
Regularity refers not to the number of GP visits, but 
rather measures the dispersion of GP visits over time, with 
more even dispersion indicating better regularity. It has 
been shown previously that the use of financial incentives 
to GPs increases the regularity of primary care contact 
in the following year without increasing frequency of 
contact.19 More recently, we have reported decreased 
rates and costs of diabetes-related hospitalisations with 
increasing GP regularity.20 This finding suggests that 
regularity is potentially suitable as a target for policy inter-
vention and provides some justification for the interpre-
tation of regular primary care as indicative of proactive 
management of a patient or condition, as opposed to 
reactive or unplanned care. An important limitation of 
previous work has been the inability to adjust for conti-
nuity of provider when evaluating the impact of regularity. 
No attempt at disentangling the impact of regularity from 
that of provider continuity has been reported to date. 
Thus, despite the relevance for policy development, 
whether increased regularity is actually a proxy for, or a 
consequence of, increasing continuity of provider, or is a 
discrete facet of continuity of care is unknown.
The aim of this study was to assess the continuity of 
provider-adjusted association between regularity of GP 
contact and unplanned diabetes-related hospitalisations 
and emergency department (ED) presentations.
MethODs
study design
This was an observational cross-sectional study using 
self-reported survey data linked with routinely collected 
unit record administrative health data from 1 July 2009 to 
30 June 2015. Reporting follows the Reporting of studies 
Conducted using Observational Routinely collected 
health Data (RECORD) guidelines.21
Patient and public involvement
A consumer representative was involved in the design 
of the grant used to fund this research. The 45 and Up 
Study, which provided data for this project, maintains a 
repository of published research using this cohort online.
Data sources
The study used both self-reported and routinely collected 
administrative data linked at the person level from the 45 
and Up Study.22
The Sax Institute’s 45 and Up Study is a longitudinal 
cohort study of 2 66 885 participants, aged 45 years and 
above in the state of New South Wales (NSW), Australia. 
Prospective participants were randomly sampled from the 
Australian Government Department of Human Services 
(DHS), formerly Medicare Australia, enrolment database 
and recruited from 2006 to 2009. The study methods 
are described in detail elsewhere.22 Briefly, participants 
completed a baseline health and lifestyle questionnaire 
and consented to follow-up and linkage to routine health 
databases. The overall response rate was 18%.22
The data sources linked and used in this study included: 
(1) the 45 and Up Study baseline questionnaire (https://
www. saxinstitute. org. au/ our- work/ 45- up- study/); (2) the 
NSW Admitted Patient Data Collection (APDC) which 
provided all hospital separations in public and private 
hospitals in NSW (2005–2015); (3) the NSW ED Data 
Collection (EDDC) which provided information on all ED 
presentations from 2006 to 2015; (4) the Pharmaceutical 
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Benefits Scheme (PBS) which provided information on 
subsidised prescription medicines dispensed (2005–
2015); (5) the Medical Benefits Schedule (MBS) which 
provided records for all claims for medical and diagnostic 
services provided through Medicare, Australia’s universal 
health insurance scheme (2005–2015) and (6) the NSW 
Register of Births Deaths and Marriages (RBDM) (2006–
2015). The linkage of APDC, EDDC and RBDM to the 
survey data was conducted by the NSW Centre for Health 
Record Linkage. MBS and PBS data were linked by the 
Sax Institute using a unique identifier provided by the 
DHS. Quality assurance data on the data linkage show 
false-positive and false-negative rates of <0.5 and <0.1%, 
respectively.23
Ascertainment of previous history of diabetes and entry into 
the study cohort
This study used a cohort of 45 and Up Study participants 
with a history of diabetes mellitus (excluding malnutri-
tion-related diabetes mellitus, International Statistical 
Classification of Diseases, 10th Revision, Australian 
Modification (ICD-10-AM) code E12) on or before 31 
December 2009. This was ascertained via: (1) self-report 
from the baseline questionnaire using the question ‘Has 
a doctor ever told you that you have diabetes?’; (2) evidence 
of hospitalisation indicating diabetes from 2005 to 2009 
using the ICD-10-AM codes E10, E11, E13, E1424 or (3) 
a PBS claim indicating a dispensing from 2005 to 2009 
using the following Anatomical Therapeutic Chemical 
codes A10A (insulins and analogues) and A10B (blood 
glucose lowering drugs excluding insulins).
Participant inclusion and exclusion criteria
We included participants with diabetes who had at least 
three GP contacts (minimum required for the UPC 
metric) during the study period. We excluded participants 
who died before 30 June 2011 to allow for a minimum of 
2 years of follow-up (figure 1). Exposure (ie, patterns of 
GP contact) and outcomes were ascertained from 1 July 
2009 to 30 June 2015 or, for participants who died during 
the study period, until the end of the financial year (ie, 30 
June) prior to death. Over the follow-up period, a small 
but unknown number of participants may have moved out 
of NSW, where no data were collected. This would then 
affect collection of outcome and exposure data beyond 
the date in which the individual left NSW. Among those 
continuing to reside in NSW, follow-up for hospitalisation 
is considered to be ~98%.25
Outcomes
Study outcomes were the number, associated bed days 
(for hospitalisations) and cost of unplanned diabetes-re-
lated hospitalisations or ED presentations occurring 
during the study follow-up period.
Hospitalisations included those classified as diabe-
tes-related potentially preventable hospitalisations by the 
National Health Performance Framework (E10, E11, E13, 
E14)24 or where diabetes was identified as a significant 
risk factor by Davis et al.26 The ICD codes listed by Davis et 
al were those where diabetes was considered to increase 
the risk of hospitalisation for that condition. The list is 
freely available on table 1 of these authors’ publication.26 
Diabetes related, rather than all hospitalisations were 
chosen as an outcome because primary care for a cohort 
Figure 1 Cohort flow diagram. GP, general practitioner.
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defined by having diabetes could not be reasonably 
expected to be associated with lower all-cause hospitalisa-
tion, and thus any association identified would be outside 
of the study aims. Hospitalisations were further limited 
to those identified as unplanned, identified using the 
Emergency status (urgency of admission) variable in the 
APDC, as these are most likely the hospitalisations that 
are most amenable to the potentially protective effect of 
better continuity of primary care. Same-day hospitalisa-
tions for routine dialysis were excluded.
Unplanned diabetes-related ED presentations were 
ascertained from EDDC data using either the ICD diag-
nosis or the Systematized Nomenclature of Medicine—
Clinical Terms (SNOMED-CT) code, depending on 
availability in the data. ICD codes used to capture diabetes 
were those detailed above mapped to the ICD version 
used on the EDDC record. SNOMED-CT codes included 
those with a description relating to diabetes excluding 
where the wording included ‘not related to diabetes’ or 
relating to diabetes insipidus.
Interhospital transfers, as well as ED admissions 
resulting in hospitalisation, were counted as a single 
episode of care, with bed days calculated for each single 
episode of care.
Hospitalisation costs were assigned based on average 
public hospital Australian Refined Diagnostic-Related 
Group (AR-DRG) costs reported in the National Hospital 
Cost Data Collection round 18 (2013/2014) as this was 
the most recent year of DRG costing in the APDC data.27 
Costs were applied based on the AR-DRG code recorded 
for each admission. Cost of ED presentations was deter-
mined using cost weight for each urgency disposition 
group (UDG) using the National Efficient Price Weight 
Determination 2018–2019 Price Weight table.28 UDGs 
classify patients into 12 groups based on the type of 
visit, episode end status and triage code.29 UDGs were 
generated to reflect the UDGs reported on the National 
Hospital Cost Data Collection on the basis of the triage 
category,1–5 mode of separation and visit type reported in 
the EDDC data. All costs were inflated to 2017 Australian 
dollars using the Consumer Price Indices and included 
costs of nested events, where present.30
exposures
GP contact was captured via MBS claims for ‘Attendances 
by General Practitioners’.31 We used a modified version of 
the regularity index, described previously.19 Both indices 
use the number of days between GP visits within an ascer-
tainment period. Whereas the original regularity score 
(RV) was constructed using the formula RV=1/(1+variance 
(days)), the modified regularity index was calculated 
using the coefficient of variation (Cv) in place of the vari-
ance. Cv was calculated with the formula:
 
 
Cv =
(
sd(days)
mean(days)
)
∗ 100
 
 
The modified index produces a unitless measure of vari-
ation, which is less correlated with frequency compared B
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with previous measures.20 The modified regularity index 
(RCv) was constructed using the formula RCv=1/(1+Cv 
(days)). This resulted in a score between 0 and 1 per 
individual, with 1 indicating perfectly regular contact. 
This score was separated into quintiles from least to most 
regular, using the range of scores observed in the cohort.
In addition to regularity we also used UPC, which 
calculates the proportion of all GP visits made to the most 
frequently seen GP over the study period and ranges from 
0 to 1.15 32 UPC was measured over the study period using 
deidentified provider numbers in the MBS data.
study covariates
The 45 and Up Study questionnaire data included self-re-
port information on key potential confounders and medi-
ating factors including: baseline age; sex; marital status; 
born in Australia; Indigenous status; current housing; 
household income; education level; smoking history, 
intensity and age stopping; alcohol use; physical activity33; 
time spent sitting; body mass index; psychological 
distress34; level of limitation reported; social support35; 
socioeconomic status36; and Accessibility/Remoteness 
Index of Australia.37 Covariate categories are provided in 
online supplementary file 1.
Comorbidity was ascertained using the Multipurpose 
Australian Comorbidity Scoring System,38 defined as the 
sum of comorbidities excluding diabetes at 1 and 5 years 
prior to study entry. We also used the PBS data to calcu-
late the Rx-Risk index (ie, number of condition groups 
excluding diabetes for which medicines were dispensed) 
at 1 and 5 years prior to entry to the study period.39
Health service use during and prior to the study 
period was captured in several ways. The number of GP 
and specialist physician visits 4 years before and during 
the study period was ascertained separately using MBS 
data. The frequency of contact was captured as: (1) a 
count of the number of days each person had a GP or 
specialist physician contact and (2) the SD of the annual 
count of days with a contact during the ascertainment 
period. Variables also captured if participants had a PBS 
records for any diabetes-related medicines, hospitalisa-
tions for dialysis, MBS diabetes cycle of care claim40 and 
other chronic disease related MBS-funded primary care 
services or glycosylated haemoglobin (HbA1c) testing 
during or in the 4 years prior to the study period. Finally, 
the number of unplanned diabetes-related hospitalisa-
tions and ED presentations in the 3 years prior to study 
entry was also included as a potential confounding 
factor.
To reduce ascertainment bias, the method (ie, self-re-
port only, APDC only, PBS only or combinations of the 
three) and first year the individual who identified as 
having diabetes was entered into the model. In addition, 
a binary variable was used to determine if the participant 
died during the 6 years of the study period. Person-time 
at risk of the outcome event was included in the count 
models.
statistical analysis
Analyses were conducted using Stata SE Version 15 (Stata, 
College Station, Texas, USA). The relationship between 
regularity, UPC and count outcomes was evaluated in two 
stages.41 First, a logit model was fitted for the probability 
of observing the relevant outcome. Second, a negative 
binomial model, conditional on a positive outcome was 
developed. The number of days out of hospital (condi-
tional on being alive) was used as the time at risk variable 
for the number of unplanned diabetes-related hospi-
talisations and ED presentations, while the number of 
years in the study cohort under observation was used 
as the exposure variable in the evaluation of number 
of bed days for unplanned diabetes-related hospitalisa-
tions. The overall relationship, accounting for the prob-
ability of having an outcome, was subsequently evaluated 
using zero-inflated negative binomial (ZINB) multivari-
able regression, which included separate components 
to model zero and non-zero outcomes to account for 
overdispersion of the data and the high proportion of 
person-time with no outcome. The previously defined 
logit and negative binomial models were used for each 
part of the ZINB model. For the cost outcome, a two-part 
model (Stata -twopm-) incorporating a logit (first part) 
and generalised linear model (GLM) with a gamma 
family and a cubed root link function for the second part 
were used. The GLM family was determined using the 
Modified Park Test. The most appropriate link function, 
conditional on the gamma family, was then evaluated 
using power links in 0.1 intervals between 1 (identity) 
and 0 (log) using Akaike Information Criterion (AIC)/
Bayesian Information Criterion (BIC) and the Pearson 
correlation test. Once the best link function was deter-
mined, the specification of the model was evaluated 
using the link test.
Since the model used for cost (Stata -twopm- module) 
is a wrapper that facilitates computation of the combined 
marginal effects and adjusted predictions from the two 
separate models (logit and conditional GLM), compara-
tive coefficients (ie, inflated for the probability of a zero 
outcome) across the outcomes do not exist. Further, the 
coefficients from the ZINB models cannot be directly 
interpreted as the impact of regularity adjusting for the 
probability of having an event. Rather, average marginal 
effects (AMEs) need to be estimated. Thus, to facilitate 
comparison of the impact of regularity and UPC, consid-
ering the probability of having an event in this population 
across outcomes, the AMEs, rather than the coefficients, 
were reported.
Models were built using backwards selection with reten-
tion of covariates in the parsimonious model based on 
statistical significance (p≤0.05) or a change in the effect 
size in respect to regularity of ≥10%. Regularity and UPC 
were retained in all models a priori. Competing models 
were evaluated using the AIC and BIC. All models incor-
porated robust SEs.
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results
Cohort characteristics
Nine per cent (23 926) of 45 and Up Study partici-
pants self-reported a diagnosis of diabetes (figure 1). 
Of those not self-reporting a diagnosis of diabetes, 3373 
had a diabetes-related hospitalisation prior to 2010 and 
3038 of the remaining 239 586 had a diabetes medicine 
dispensed. The resulting diabetes cohort of 30 337 was 
reduced to 27 409 due to potential linkage error (n=182), 
dying prior to 1 July 2011 (n=2264) or having less than 
three GP visits during the study period (n=482).
Cohort characteristics and unadjusted outcomes are 
summarised in table 1, with full characteristics defined 
by regularity quintile and UPC category in online supple-
mentary file 2. At entry, the diabetes cohort was 46% 
female. The mean age was 68 years and 1.4% of the 
cohort was Indigenous. The majority (71%) were born in 
Australia and 73% were obese or overweight. Just over half 
were never smokers (51%), had a tertiary qualification 
(55%) and lived in a ‘highly accessible’ location (53%). 
The cohort was followed for a mean of 5.7 years and aver-
aged 13 GP visits annually. The mean reported days with 
a GP visit throughout the 6-year study period was higher 
for the lowest quintile of regularity (69) than the highest 
quintile of regularity (66). The number of diabetes ‘cycle 
of care’ MBS claims, HbA1c tests and chronic disease 
management plans were higher for the highest quintile 
of regularity than for the lowest. Eighteen per cent died 
during follow-up, with 26% of the deaths coming from 
the lowest quintile of regularity. Twenty-one per cent of 
the diabetes cohort had a diabetes-related hospitalisation 
or ED presentation during the study period. Forty-three 
per cent of participants had a UPC between 0.76 and 1.00 
(online supplementary file 2). There was a positive crude 
association between increasing UPC and increasing regu-
larity (table 1).
Outcomes of conditional models
Table 2a shows the coefficients for regularity and UPC 
from the multivariable logit model of unplanned diabe-
tes-related hospitalisation or ED presentation. The full 
model output is shown in online supplementary file 3. 
A reduction in the probability of unplanned diabetes-re-
lated hospitalisation or ED presentation was observed 
for each subsequent quintile compared with the lowest 
quintile ranging from −0.13 to −0.28. Relative changes in 
the probability of an unplanned diabetes-related hospi-
talisation alone were similar (online supplementary 
file 3). Increasing UPC did not significantly change the 
probability of an unplanned diabetes-related hospitalisa-
tion or ED presentation (−0.03, 95% CI −0.19 to 0.13). 
The adjusted probability of an unplanned diabetes-re-
lated hospitalisation or ED presentation over a 6-year 
period was on average 0.23 for individuals in the lowest 
quintile of regularity and reducing to 0.20 for those in 
the highest regularity quintile (figure 2A). UPC did not 
modify the association between quintile of regularity and 
the predicted probability of having a diabetes-related 
hospitalisation or ED presentation (online supplemen-
tary file 4a).
Table 2b–d shows the model outputs for study 
outcomes, conditional on having one or more events over 
the study period; the full model outputs are shown in 
online supplementary file 5. There was no consistent asso-
ciation between increasing regularity and the number of 
diabetes-related hospitalisations or ED presentations. The 
relative number of unplanned diabetes-related hospi-
talisations was significantly reduced for those with low 
(−6%, 95% CI −13% to 0%) and moderate (−8%, 95% CI 
−15% to −2%) compared with those with the lowest regu-
larity. However, no significant difference existed between 
individuals in the highest two quintiles of regularity and 
their counterparts who had the lowest regularity. UPC 
was associated with a decrease in the relative number 
of diabetes-related hospitalisations or ED presentations 
(−11%, 95% CI −21% to −1%). Predicted diabetes-related 
hospitalisations or ED presentations per 100 person-years 
at risk ranged from ~38 in the lowest and high quintiles 
of regularity to 35 in the moderate quintile of regularity 
(figure 2B). Increasing UPC was independently asso-
ciated with a reduction in the adjusted rate of diabe-
tes-related hospitalisations or ED presentations, but the 
association was not differential by quintile of regularity 
(online supplementary file 4b).
There was a clear negative association in the relative 
number of bed days, conditional on an event occurring; 
−30% (CI −38% to −22%) for low to −44% (95% CI −53% 
to −36%) for high quintile compared with the lowest 
regularity quintile (table 2c). Conversely, UPC was also 
positively associated with the relative number of bed days 
(17%, 95% CI 4% to 30%). The adjusted predicted rate 
of bed days decreased by quintile of regularity, with a 
predicted 561 bed days per 100 person-years at risk for 
the lowest quintile of regularity, and 373 bed days for the 
highest quintile of regularity (figure 2C). No differential 
effect of quintile of regularity by UPC score was observed 
(online supplementary file 4c).
A similar trend as described for bed days was observed 
for cost, with all coefficients negative relative to the lowest 
regularity quintile (table 2d). The reduction in cost rela-
tive to the lowest quintile was greatest in the high quin-
tile (−41%, 95% CI −56% to −27%), with a slightly lower 
reduction observed in the highest quintile (−39%, 95% CI 
−55% to −23%). The adjusted predicted annual cost per 
100 person-years at risk shows a range from $A1 154 557 
for the lowest to $A784 507 for the high quintile of regu-
larity. No significant association with UPC was observed 
(13% increase, 95% CI −9% to 36%). Online supplemen-
tary file 4d shows a non-differential effect of UPC by quin-
tile of regularity.
Outcomes of unconditional models
There was no significant difference in the number of 
diabetes-related hospitalisations or ED presentations across 
quintiles of regularity, when accounting for the probability 
of having an event (table 3). Similarly, the association of 
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regularity on bed days for unplanned diabetes-related hospi-
talisation became non-significant. In comparison, there was 
a significant negative association between regularity and 
cost across all regularity quintiles but as described below 
the magnitude of the association was substantially reduced 
from that observed in the conditional model. The AMEs of 
regularity in the conditional cost model range from −$A12 
920 (95% CI −$A21 2800 to −$A4560) for the low regularity 
quintile to −$A22 200 (95% CI −$A30 290 to −$A14 120) 
for the high regularity quintile. However, the AMEs for the 
same quintiles were reduced by approximately 70% when 
the probability of having a hospitalisation/ED presenta-
tion was incorporated into the model: −$A3798 (95% CI 
−$A5831 to −$A1765) for low regularity to −$A6530 (95% 
CI −$A8505 to −$A4556) for high regularity. The signifi-
cant positive AMEs with increasing UPC with respect to bed 
days and cost in the conditional models disappeared in the 
unconditional models.
DIsCussIOn
The probability of having an unplanned diabetes-re-
lated hospitalisation or ED presentation was inversely 
Figure 2 Adjusted* predictions stratified by quintile of general practitioner (GP) regularity for: (A) the probability of having one 
or more diabetes-related hospitalisation or emergency department (ED) presentations; (B) rate of diabetes-related hospitalisation 
or ED presentation; (C) rate of bed days and (D) associated costs ($A 2017 in 1000 s). (B), (C) and (D) are per 100 person-years 
at risk conditional on having one or more diabetes-related hospitalisation or ED presentations. *(A) Adjusted for: UPC index, 
age, sex, method of identification in diabetes cohort, earliest year of diabetes observation, years of follow-up, number dying 
during follow-up, Indigenous status, marital status, accessibility/remoteness, socioeconomic status, highest level of education, 
pretax annual income, number of cigarettes smoked, physical activity level, level of limitation, level of social support, 1-year and 
5-year Rx score, 5-year multipurpose Australian comorbidity scoring system score, years with a dialysis admission, years with 
a Pharmaceutical Benefits Scheme (PBS) record for insulin, years with a PBS record for other diabetes medication, average 
annual specialist visits, average annual GP visits, SD annual GP visits, average annual specialist visits in previous 4 years, 
average annual GP visits in previous 4 years and number of diabetes-related hospitalisations or ED presentations in previous 
3 years. *(B) Adjusted for: UPC index, age, sex, earliest year of diabetes observation, years of follow-up, number dying during 
follow-up, marital status, accessibility/remoteness, pretax annual income, 5-year Rx score, 1-year and 5-year multipurpose 
Australian comorbidity scoring system score, number of years with a dialysis admission, years with a PBS record for insulin, 
years with a PBS record for insulin in previous 4 years, average annual specialist visits, number of enhanced primary care/
chronic disease management plans, SD of annual days with a GP visit, average annual specialist visits in previous 4 years, 
average annual GP visits in previous 4 years, number of diabetes ‘cycle of care’ claims in previous 4 years and number of 
diabetes-related hospitalisations or ED presentations in previous 3 years. *(C) Adjusted for: UPC index, age, sex, number dying 
during follow-up, marital status, accessibility/remoteness, age stopping smoking, annual pretax income, socioeconomic status, 
living independently (yes/no), physical activity level, hours spent sitting per day, 1-year and 5-year multipurpose Australian 
comorbidity scoring system score, years with a PBS record for insulin in the previous 4 years, years with a PBS record for 
other diabetes medication in previous 4 years, SD of annual specialist visits, number of enhanced primary care/chronic disease 
management plans, number of diabetes ‘cycles of care’ claims, number of glycosylated haemoglobin claims, average annual 
number of days with a GP visit, average annual number of GP visits in previous 4 years, average annual regularity score in 
previous 4 years, number of diabetes ‘cycle of care’ claims in previous 4 years and number of diabetes-related hospitalisations 
or ED presentations in previous 3 years. *(D) Adjusted for: UPC index, sex, number dying during follow-up, born in Australia 
(yes/no), accessibility/remoteness, smoking status, 5-year multipurpose Australian comorbidity scoring system score, years with 
a dialysis admission, SD of annual number of specialist visits, years with a PBS record for non-insulin diabetes medication in 
previous 4 years, average annual specialist visits in previous 4 years, average annual regularity score in previous 4 years.
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associated with regularity of GP contact, after adjusting 
for continuity of provider. Conditional on having an 
event, increasing regularity was associated with both a 
lower cost and reduced days in hospital. The association 
with cost, while somewhat attenuated, persisted when the 
probability of having an event was taken into account. 
However, the association was not significant with respect 
to bed days.
These findings lend support to primary care policies 
where proactive managed care by any GP is incentivised. 
In Australia, there is no formal requirement to register at 
a GP practice, whereas in the United Kingdom, people 
need to register with the National Health Service at a 
single GP practice.42 Campbell et al12 43 report a fall in 
continuity of provider following implementation of the 
Quality Outcomes Framework (QOF), a practice-level 
financial incentive to improve clinical management 
of chronic disease in the United Kingdom. Our results 
suggest that this might not matter in terms of achieving 
a reduction in hospitalisations for people with diabetes, 
since the effect for regularity was larger than those of 
UPC when modelled together. This suggestion is corrob-
orated by a slight fall in emergency hospitalisations for 
practices with more diabetic patients with moderate, 
as compared with poor glycaemic control, in England 
following implementation of the QOF.44 While there is 
no QOF in Australia, initiatives such as the MBS diabetes 
‘cycle of care’ payment are similarly aimed at improving 
the quality of chronic disease management.40 Also using 
45 and Up Study survey data, Comino et al45 have reported 
a lower adjusted rate of hospitalisation for people with 
diabetes for whom a diabetes cycle of care was prepared, 
or a GP management plan reviewed. Diabetes complica-
tions vary in both number and severity.46 The association 
between increasing regularity and fewer bed days (in the 
unconditional model) and lower cost (in both models) 
may indicate a lower severity of complications on average 
at hospital admission. Increasing regularity of GP contact 
will not completely negate unplanned hospitalisations, 
though timely intervention may allow hospital-level care 
to be initiated earlier. For example, a diabetic foot ulcer 
may still require hospitalisation for management, but 
avoid progression necessitating more severe and costly 
management.47 Ballo et al48 in a study assessing chronic 
care management for people with heart failure found an 
increase in hospitalisation among this group compared 
with controls. This was primarily driven by planned 
hospitalisations, for which there was a greater increase 
relative to unplanned. Once in place, removal of quality 
incentives can also change clinician behaviour, as shown 
recently with a decrease in documented quality measures 
following cessation of some of the UK’s QOF elements.49
For the cost outcome, the AME was −$A6530 for the 
high quintile of regularity yielding a total cohort hospi-
talisation cost reduction of $A179 million. The cost-ef-
fectiveness of increasing regularity is out of scope of 
this study; however, this is a potential avenue for further 
study. Another important issue to consider is whether 
modelled outcome changes by regularity quintile are due 
to inherent differences in the people occupying each 
quintile, with these differences rather than any effect 
from GP care explaining the observed differences. There 
were some demographic differences across quintiles as 
indicated in table 1. In our study, a wide range of covari-
ates were accessible including sociodemographic, psycho-
social, health behaviours and prior health service use, 
and while we cannot rule out residual confounding, the 
adjustment for a wide range of covariates that could plau-
sibly affect the association reduces the risk of substantial 
confounding affecting interpretation.
Previous work has demonstrated an association between 
managed care and hospitalisations.18 50 Barker et al51 have 
reported an association between increasing UPC and 
fewer ambulatory care sensitive condition hospital admis-
sions, with a 6.2% decrease per 0.2 increase in UPC. Admis-
sions for 22 conditions were considered by these authors 
making the study cohort more heterogeneous than the 
single-condition cohort in this study. These authors 
adjusted for GP frequency, but not regularity. While 
determination of the impact of continuity of provider was 
not the aim of our paper, we found a negative association 
between UPC (adjusted for regularity of contact) and the 
days spent in hospital and cost of unplanned diabetes-re-
lated hospitalisations or ED presentations, conditional on 
an event occurring. However, a negative association with 
the number of unplanned diabetes-related hospitalisa-
tions or ED presentations was not observed. Our results 
are, therefore, discordant with literature reporting a nega-
tive association between continuity of provider and hospi-
talisation.51–57 This may be explained by our simultaneous 
adjustment for regularity and continuity of provider. If 
increased continuity of provider improves regularity of 
contact, then studies reporting UPC without adjusting for 
regularity may have not differentiated between these two 
facets of continuity of care.
This study had several strengths. Adjustment for both 
regularity and continuity of provider shows that the asso-
ciation between regularity and study outcomes is not 
solely due to frequency or continuity of provider. The 
availability and inclusion of covariates from the 45 and 
Up Study and administrative data have also helped to 
reduce the risk of associations being due to different char-
acteristics in each regularity quintile. Effect modification 
was investigated by testing the significance of an interac-
tion term and reporting the association with regularity 
across the levels of UPC. Our definition of the outcome 
as being unplanned diabetic-related hospitalisation or 
ED presentations has also facilitated a deeper analysis of 
the impact of GP contact on a subset of diabetic-related 
hospitalisations that are more likely to be amenable to 
change by high-quality primary care. The two-part analyt-
ical methods allowed results to be presented both condi-
tionally and unconditionally. This allowed assessment of 
the association between regularity and the probability 
of hospitalisation, the impact on additional hospitalisa-
tion for those previously hospitalised and overall for the 
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population with diabetes. The latter is important because 
primary care policies are usually implemented across 
populations, and thus determining the value (impact vs 
cost) of the policy overall is important. Identifying if the 
impact differs across subpopulations is also informative, as 
this knowledge may facilitate more targeted approaches 
to policy development. There were also limitations to this 
study. This was a cross-sectional observational study over a 
6-year period. In this study, we have reported associations, 
rather than to make any causal inferences. Temporal 
ordering of exposure followed by outcome is not given 
because of the cross-sectional study design. The lack of 
detail (eg, of length of GP consults or clinical data to indi-
cate disease severity) in the analysis also reduces the level 
of detail analysed regarding these interactions. Migration 
outside of NSW leads to loss to follow-up. Based on mean 
total international and interstate migration for NSW 
between 2009/2010 and 2014/2015 (financial years), this 
proportion is at most 4.8%.58–60 However, 81.3% of these 
people were aged below 44 years and thus, while the total 
proportion of study participants affected is unknown, 
the impact on results is likely to be minimal (<1% of 
cohort). The results of this study are not generalisable to 
people with diabetes below the age of 45 years. Though 
the response fraction in the 45 and Up Study is 18%, the 
generalisability of results has been assessed by comparing 
effect measures for this cohort with those from the NSW 
Population Health Survey, which had a ~60% response.61 
These authors concluded that their ‘findings show that 
broad ranges of exposure-outcome relationships esti-
mated from two studies of the same population remained 
consistent regardless of the underlying response rate’.61
COnClusIOns
This is the first study to assess both regularity and conti-
nuity of provider in primary care, demonstrating an inde-
pendent association between increasing GP regularity and 
the probability of an unplanned diabetes-related hospi-
talisation or ED presentation, bed days and associated 
costs. Based on these results, continuity of provider and 
regularity should be considered as distinct phenomena in 
future analyses, since this would aid in determining which 
facets of continuity are driving outcomes and aid in deci-
sions regarding promotion of incentives that support (1) 
ongoing contact with the same provider (without a focus 
on regularity of care), (2) regular care (by any provider) 
or (3) regular care by the same provider. Future research 
should incorporate a measure of regularity, separate 
from provider continuity, to enable further assessment of 
systems-level policies to improve chronic disease manage-
ment in settings with a range of funding models in 
primary care. The findings in this study argue for chronic 
disease management incentives which are not necessarily 
tied to a provider and invites similar adjustment in future 
analyses assessing the impact of GP-led primary care 
financial incentives. Given falling continuity of provider 
in some settings, levers to improve coordination of care 
irrespective of provider may help to reduce secondary 
care requirements for chronic conditions managed in 
primary care.
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